P03-49 - Efects of rivastigmine tartrate in therapy of schizophrenic patients
European Psychiatry(2010)
Abstract
Conclusions Dual cholinesterase inhibitors (Acetilcholine and Butirilcholine) may produce improvement in cognition and behavioural performances, as well as the general quality of life of patients diagnosed with residual schizophrenia. Future studies applied on this kind of patients should precisely explain the basic pharmachological mechanisams of rivastigmin tartrate, and approve/disapprove the results of clinical studies and case reports that have been preformed so far.
MoreTranslated text
Key words
cognitive functioning,rivastigmin tartarat,scizophrenia,cognitive function
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined